ArticleGut pathogens2025
Epidemiological, clinical, and molecular characteristics of coxsackievirus A2 infections during a herpangina outbreak in children on an Island in Eastern China in 2024: a surveillance-based study.
Article in Gut pathogens, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
backgroundHerpangina is an acute pediatric illness caused by enteroviruses, yet the predominant circulating serotype in mainland China has not been well characterized. In this study, Coxsackievirus A2 (CV-A2) emerged as the dominant serotype among herpangina cases in Yuhuan City, Zhejiang Province. These findings underscore the importance of further research into the epidemiological distribution and molecular features of CV-A2 in this region.
methodsA total of 133 child herpangina cases were included during May and June 2024. Enteroviruses were detected using RT-PCR, followed by serotyping and sequencing. Phylogenetic and recombination analyses were performed to assess genetic diversity and evolutionary relationships.
resultsAmong the 133 cases (median age: 3 years), 88.7% tested positive for enteroviruses. CV-A2 was predominant (78.0%), followed by CV-A4, CV-A5, CV-A10, CV-A16, and CV-B4. Fever (95.5%) and oral vesicles (98.5%) were the most common symptoms. Compared to other serotypes, CV-A2 cases had a higher incidence of fever (P = 0.008) and peak temperature (P = 0.042), with significantly elevated neutrophil percentages (> 70.0%) and reduced lymphocyte percentages (< 20.0%). Phylogenetic analysis identified genotype D accounted for 97.8% (90/92) of CV-A2 strains; two genotype C strains clustered with European isolates. Recombination analysis revealed intra- and inter-serotype events involving CV-A2, A4, and A5.
conclusionCV-A2 has re-emerged as the dominant herpangina-associated enterovirus in Eastern China, demonstrating distinct clinical and hematological features. This shift in serotype prevalence underscores the need for continued surveillance to monitor its spread and interactions with other serotypes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.